CASE STUDIES INTRIALS RECRUITMENT AND SITE MANAGEMENT STRATEGIES WERE INFLUENTIAL TO EXCEED CLIENTS’ EXPECTATIONS IN PIVOTAL IND PHASE III COMPLEX LUNG AND PANCREAS CANCER TRIALS. The successful enrollment of these two studies, both with complex protocols and procedures, in a highly sought-after patient population, bear the example of our successful strategy in implementing Phase III oncology trials in Brazil. Our expertise in oncology continues to be further strengthened, with new ongoing cancer trials in breast cancer treatment and prostate cancer prevention.  Between early 2001 and late 2003, INTRIALS managed and monitored in Brazil two mega global Phase III trials in non-small cell lung cancer (NSCLC) and pancreas cancer patients. Both protocols were designed to evaluate safety and efficacy of an epidermal growth factor inhibitor as measured by time-to-disease progression.  Both studies started in 2001 and, because of INTRIALS’ successful unique recruitment and site management strategies, patient enrollment for both studies was met many months before deadline. This created the opportunity to increase the accrual of enrolled subjects in Brazil far beyond the initial target.  INTRIALS in Brazil led all other countries in both studies. The NSCLC trial accrued 157 subjects in 12 months and the pancreas cancer trial accrued 16 subjects in 10 months.  Contact us to access a presentation about the region and to learn more about how INTRIALS can assist you conduct studies in Latin America.                                                                                                                       << back